Chiugray - Assuming BP can't afford to BO NWBO's full addressable market value, it would be of greater interest to longs to get a realistic idea of what a licensing structure looks like, and how the revenue growth looks short and longer term. Otherwise, we get what the platform is all about. But how does monetizing look?
Long time investor here...Although Bullish and quite hopeful in regards to NWBO's DCvax platform...I think, in this post, there may be a fundamental misunderstanding of benign and malignant tumors and how they are managed.